Combination treatment of PV and primary MF CD34+ cells, followed by transplantation into immunodeficient mice, decreased the extent of donor-derived chimerism as well as the JAK2 V617F allele burden, suggesting that such combinatorial approaches may deplete MPN hematopoietic stem cells [170]. The gene discussed is CD34; the disease is myeloproliferative neoplasm.